ZURICH/BERLIN, Feb 29(Reuters) - Here are some of the
main factors that may affect Swiss stocks on Thursday:
GALDERMA
Swiss dermatology company Galderma on Thursday said it
generated more than $4 billion in net sales during 2023, up 8.5%
on 2022 on a constant currency basis, driven by momentum across
its dermatological skincare and injectable aesthetics products.
ADECCO ADEN.S
Q4 results due.
CLARIANT CLN.S
Full year results due.
COMPANY STATEMENTS
*VZ Holding AG VZN.S reported full-year net profit up
23.5% at 187 million Swiss francs ($212.81 million). VZN.S
*Bystronic AG BYS.S reported full-year net income of 42
million Swiss francs and said it plans a cost optimization
programme. BYS.S
ANALYSTS' VIEWS
ALCON AG ALCC.S : JP MORGAN RAISES TARGET PRICE TO CHF 85.1
FROM CHF 74.4
ECONOMY
Swiss Q4 GDP due at 0800 GMT. Seen +0.1% Q/Q, +0.7% Y/Y
Swiss February KOF indicator due at 0800. Seen at 102.0
Swiss January official reserves assets due at 0800
($1 = 0.8787 Swiss francs)
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))